跳至主導覽 跳至搜尋 跳過主要內容

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers

新聞/媒體: Press/Media

期間26 4月 2023

媒體報導

1

媒體報導

  • 標題Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
    媒體名稱/出口Genomebiology.Biomedcentral.com
    國家/地區United Kingdom
    日期26/04/23
    人員YAPENG WANG